Quantifying DNA point mutations in commercially available AAV reporter vectors and plasmids

To compare the accuracy of three sequencing methods for quantifying point mutations in AAV products, we sequenced the green fluorescent protein (GFP) transgene from two AAV9 reporter vectors (three lots each) and their respective plasmids, using three sequencing approaches: single-template amplification (STA) followed by Sanger sequencing (STA-Sanger) and two next-generation sequencing (NGS) platforms (Illumina and Oxford Nanopore Technologies [ONT]). Similar vector per-base mutation rates were found for both STA-Sanger (0.016%) and Illumina (0.013%), with slightly lower rates in plasmid sequences (STA-Sanger: 0.0019%; Illumina: 0.0074%), whereas ONT per-base mutation rates were much higher (vector: 2.2%; plasmid: 1.3%). The non-reference majority variant frequency (MVF) was more strongly correlated among vector lots for ONT (R<sup>2</sup> = 0.91) compared with Illumina (R<sup>2</sup> = 0.46), although correlation between plasmid and vectors was similar for both platforms (R<sup>2</sup> = 0.23) and virtually non-existent between platforms for the same sample (R<sup>2</sup> < 0.05). Overall, our results showed evidence for single-nucleotide mutations in AAV products, although there was a lack of consistency among sequencing platforms, which underscores the need for the AAV industry to develop sequencing methodologies with improved accuracy as a standard QC protocol.

Authors

Institutions

Publication Details

Journal
Molecular Therapy — Methods & Clinical Development
Published
2025-06-02
DOI
https://doi.org/10.1016/j.omtm.2025.101501
Primary Topic
Virus-based gene therapy research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Quantifying DNA point mutations in commercially available AAV reporter vectors and plasmids

Sanford L. Boye, Susanna L. Lamers, Rebecca Rose, David J. Nolan et al.
1 links
Molecular Therapy — Methods & Clinical Development
Virus-based gene therapy research
article

Quantifying DNA point mutations in commercially available AAV reporter vectors and plasmids

Sanford L. Boye, Susanna L. Lamers, Rebecca Rose, David J. Nolan, Jonathan DaRoza
article en

Abstract

To compare the accuracy of three sequencing methods for quantifying point mutations in AAV products, we sequenced the green fluorescent protein (GFP) transgene from two AAV9 reporter vectors (three lots each) and their respective plasmids, using three sequencing approaches: single-template amplification (STA) followed by Sanger sequencing (STA-Sanger) and two next-generation sequencing (NGS) platforms (Illumina and Oxford Nanopore Technologies [ONT]). Similar vector per-base mutation rates were found for both STA-Sanger (0.016%) and Illumina (0.013%), with slightly lower rates in plasmid sequences (STA-Sanger: 0.0019%; Illumina: 0.0074%), whereas ONT per-base mutation rates were much higher (vector: 2.2%; plasmid: 1.3%). The non-reference majority variant frequency (MVF) was more strongly correlated among vector lots for ONT (R<sup>2</sup> = 0.91) compared with Illumina (R<sup>2</sup> = 0.46), although correlation between plasmid and vectors was similar for both platforms (R<sup>2</sup> = 0.23) and virtually non-existent between platforms for the same sample (R<sup>2</sup> < 0.05). Overall, our results showed evidence for single-nucleotide mutations in AAV products, although there was a lack of consistency among sequencing platforms, which underscores the need for the AAV industry to develop sequencing methodologies with improved accuracy as a standard QC protocol.

Molecular Therapy — Methods & Clinical DevelopmentVol. 33(3)
University of Florida (US), Medosome Biotec (United States) (US)
U.S. Food and Drug Administration
Zero hunger
Openalex Percentile: Top 86%
Virus-based gene therapy research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Quantifying DNA point mutations in commercially available AAV reporter vectors and plasmids — Sanford L. Boye, Susanna L. Lamers, et al. · Molecular Therapy — Methods & Clinical Development (2025) | TGRS Research Map | TGRS